FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and represents antibodies against human CD19 (anti-human CD19), methods of their preparation, pharmaceutical compositions containing these antibodies, and methods of their application.
EFFECT: invention allows expanding the range of antibodies against human CD19.
18 cl, 5 dwg, 16 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW ANTI-CD19 ANTIBODIES | 2018 |
|
RU2791445C2 |
| ANTIBODIES AGAINST PD-1 AND THEIR USE | 2018 |
|
RU2788616C2 |
| NEW BISPECIFIC ANTIGEN-BINDING MOLECULES WITH CAPABILITY OF SPECIFICALLY BINDING TO CD40 AND FAP | 2018 |
|
RU2766234C2 |
| ANTIBODIES BINDING TO GPRC5D | 2019 |
|
RU2797268C2 |
| ANTIBODIES AND CHIMERIC ANTIGENIC RECEPTORS SPECIFIC TO CD19 | 2015 |
|
RU2741105C2 |
| NEW BISPECIFIC POLYPEPTIDE COMPLEXES AGAINST CD3/CD19 | 2018 |
|
RU2788127C2 |
| ANTI-IDIOTYPIC ANTIBODIES AND METHODS RELATED TO THEM | 2017 |
|
RU2773355C2 |
| ANTI c-Met RECEPTOR PROTEIN ANTIBODIES | 2011 |
|
RU2608644C2 |
| COMPLEMENTARITY-DETERMINING REGIONS FOR BINDING CD3 AND A BISPECIFIC ANTIGEN-BINDING MOLECULE CONTAINING THEREOF | 2019 |
|
RU2738802C1 |
| NEW PSMA-BINDING ANTIBODY AND ITS APPLICATIONS | 2017 |
|
RU2762704C2 |
